• Peace of mind for the concerned consumer

    Anatara plans to develop Detach for use in farmed animals, providing an alternative to the use of antibiotics and thereby helping farmers supply antibiotic free meat.

  • Natural treatment for animal health

    Anatara’s Detach™ is a proven natural non-antibiotic treatment for diarrhoea in piglets with the potential for use in other farm livestock. More »

  • Advancing gastrointestinal health naturally

    Our product is made using an extract from pineapple stems that blocks the causes of diarrhoea. It’s a natural product that won’t contribute to the rise of so-called “superbugs” caused by the overuse of antibiotics.

Company description

Anatara Lifesciences is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Our lead product Detach™ is a natural product that will help address global concerns around the overuse of antibiotics in animals and their feed that is contributing to the rise of so-called “super bugs” that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies.

Video overview

Latest news All news

  • Anatara Lifesciences Trading Halt

    The securities of Anatara Lifesciences have been placed in Trading Halt Session State at the request of the Company, pending a release of an announcement by the Company.

    Please click here to view the ASX announcement.

  • PAC Partners initiates analyst coverage on Anatara Lifesciences

    This month PAC Partners initiated analyst coverage on Anatara Lifesciences.

    PAC has initiated coverage with a Buy rating and price target of $1.36/share.

    To download the full report, please click here.

Investors

Investors Home

Pause